Research ArticlePsoriatic Arthritis
Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs
Majed M. Khraishi, Valencia P. Remple, Samuel Silverberg, Jacqueline C. Stewart, Brandusa Florica and Louis Bessette
The Journal of Rheumatology May 2022, 49 (5) 454-464; DOI: https://doi.org/10.3899/jrheum.200609
Majed M. Khraishi
1M.M. Khraishi, MB BCh, FRCP(C), Memorial University of Newfoundland, St. John’s, Newfoundland and Labrador, Canada;
Valencia P. Remple
2V.P. Remple, MSN, PhD, AbbVie Biopharmaceuticals Sarl, Rungis, France;
Samuel Silverberg
3S. Silverberg, MD, Etobicoke General Hospital, Toronto, Ontario, Canada;
Jacqueline C. Stewart
4J.C. Stewart, MD, FRCPC, University of British Columbia, Penticton, British Columbia, Canada;
Brandusa Florica
5B. Florica, MD, PhD, FRCPC, University of Toronto, Toronto, Ontario, Canada;
Louis Bessette
6L. Bessette, MD, FRCPC, MSc, Laval University, Centre Hospitalier de l’Université Laval, Quebec City, Quebec, Canada.
REFERENCES
- 1.↵
- 2.↵
- Gladman DD,
- Antoni C,
- Mease P,
- Clegg DO,
- Nash P
- 3.↵
- 4.↵
- 5.↵
- Coates LC,
- Kavanaugh A,
- Mease PJ, et al
- 6.↵
- Government of Canada
- 7.↵
- Genovese MC,
- Mease PJ,
- Thomson GT, et al
- 8.↵
- 9.↵
- Boehncke WH,
- Alvarez Martinez D,
- Solomon JA,
- Gottlieb AB
- 10.↵
- Mease PJ,
- Ory P,
- Sharp JT, et al
- 11.↵
- 12.↵
- 13.↵
- Carrera CG,
- Dapavo P,
- Malagoli P, et al
- 14.↵
- Fagerli KM,
- Kearsley-Fleet L,
- Watson KD, et al
- 15.↵
- Iannone F,
- Lopriore S,
- Bucci R, et al
- 16.↵
- 17.↵
- Zweegers J,
- Groenewoud JM,
- van den Reek JM, et al
- 18.↵
- Michelsen B,
- Sexton J,
- Smolen JS, et al
- 19.↵
- Heiberg MS,
- Kaufmann C,
- Rødevand E, et al
- 20.↵
- Gladman DD, ACCLAIM Study Investigators,
- Sampalis JS,
- Illouz O,
- Guérette B
- 21.↵
- Van den Bosch F,
- Manger B,
- Goupille P, et al
- 22.↵
- 23.↵
- Mourad A,
- Gniadecki R
- 24.↵
- 25.↵
In this issue
The Journal of Rheumatology
Vol. 49, Issue 5
1 May 2022
Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs
Majed M. Khraishi, Valencia P. Remple, Samuel Silverberg, Jacqueline C. Stewart, Brandusa Florica, Louis Bessette
The Journal of Rheumatology May 2022, 49 (5) 454-464; DOI: 10.3899/jrheum.200609
Canadian Adalimumab Postmarketing Observational Epidemiological Study Assessing Effectiveness in Psoriatic Arthritis (COMPLETE-PsA): 12-month Results of Comparative Effectiveness of Adalimumab and nbDMARDs
Majed M. Khraishi, Valencia P. Remple, Samuel Silverberg, Jacqueline C. Stewart, Brandusa Florica, Louis Bessette
The Journal of Rheumatology May 2022, 49 (5) 454-464; DOI: 10.3899/jrheum.200609